Physician profile
Jay L Newman
NPI 1033102678
$1,643.54
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $84.63 · 2021: $21.36 · 2022: $307 · 2023: $178 · 2024: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $319.46 | 2022-2024 | Azstarys |
| Sunovion Pharmaceuticals INC. | $293.97 | 2019-2022 | |
| Allergan, INC. | $262.96 | 2019-2020 | |
| Abbvie INC. | $262.45 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $215.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.24 | 2019-2020 | |
| Adlon Therapeutics L.P. | $57.48 | 2019-2020 | |
| Shire North American Group INC | $39.73 | 2019 | |
| Lundbeck LLC | $36.27 | 2019 | |
| Daiichi Sankyo INC. | $15.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.